Te. Nordahl et al., TEMPORAL-LOBE METABOLIC DIFFERENCES IN MEDICATION-FREE OUTPATIENTS WITH SCHIZOPHRENIA VIA THE PET-600, Neuropsychopharmacology, 15(6), 1996, pp. 541-554
Regional cerebral glucose metabolic rates (rCMRglc) were compared in 1
8 unmedicated outpatients with schizophrenia and 12 normal controls us
ing high resolution positron emission tomography (PET) and the tracer
[F-18]-2-fluoro-2D-deoxyglucose (FDG). From previous work we expected
to see abnormal hippocampal rCMRglc in the patients, but no striatal a
bnormalities. Trial-by-trial Stroop cognitive task, which has been sho
wn to activate the anterior cingulate, was performed within a day of t
he PET study. As our patients performed abnormally on the Stroop we te
sted for a correlation between the anterior cingulate rCMRglc and Stro
op performance. We found no whole slice cortical average glucose metab
olic abnormalities. As predicted we found abnormally decreased left hi
ppocampal rCMRglc in the patients. No striatal or cingulate rCMRglc ab
normalities were noted in patients, but they demonstrated a highly pos
itive correlation between anterior and cingulate rCMRglc and Stroop fa
cilitation. Patients with higher Stroop interference had more prominen
t hippocampal metabolic decreases. These localized temporal lobe abnor
malities could account for some of the patient's positive symptoms and
are consistent with recent findings in the literature. (C) 1996 Ameri
can College of Neuropsychopharmacology